While skeletal muscle, ApoJ protein levels and LRP2 mRNA in PCOS subjects at baseline were not different compared to normal cycling subjects (Fig. 8f, g), pioglitazone treatment of PCOS subjects increased ApoJ protein content, as well as mRNA for LRP2 (Fig. 8h, i). The gene discussed is CLU; the disease is polycystic ovary syndrome.